The role of CYP1A1/2 in cholesterol ester accumulation provides a new perspective for the treatment of hypercholesterolemia.

Jian LU; Xuyang Shang; Bingyi Yao; Dongyi Sun; Jie Liu; Yuanjin Zhang; He Wang; Jingru Shi; Huaqing Chen; Tieliu Shi; Mingyao Liu; Xin Wang

Return

The role of CYP1A1/2 in cholesterol ester accumulation provides a new perspective for the treatment of hypercholesterolemia.

Author: Jian LU ¹ ; Xuyang SHANG ¹ ; Bingyi YAO ¹ ; Dongyi SUN ¹ ; Jie LIU ¹ ; Yuanjin ZHANG ¹ ; He WANG ¹ ; Jingru SHI ¹ ; Huaqing CHEN ¹ ; Tieliu SHI ¹ ; Mingyao LIU ¹ ; Xin WANG ¹
Author Information

1. Changning Maternity and Infant Health Hospital and School of Life Sciences, Shanghai Key Laboratory of Regulatory Biology, East China Normal University, Shanghai 200241, China.
Publication Type:Journal Article
Keywords: CES1; CYP1A; Cholesterol; Hypercholesteremia; Hyperlipidemia; LXR; Lansoprazole; Lipidosis
From: Acta Pharmaceutica Sinica B 2023;13(2):648-661
CountryChina
Language:English
Abstract: Cholesterol is an important precursor of many endogenous molecules. Disruption of cholesterol homeostasis can cause many pathological changes, leading to liver and cardiovascular diseases. CYP1A is widely involved in cholesterol metabolic network, but its exact function has not been fully elucidated. Here, we aim to explore how CYP1A regulates cholesterol homeostasis. Our data showed that CYP1A1/2 knockout (KO) rats presented cholesterol deposition in blood and liver. The serum levels of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and total cholesterol were significantly increased in KO rats. Further studies found that the lipogenesis pathway (LXRα-SREBP1-SCD1) of KO rats was activated, and the key protein of cholesterol ester hydrolysis (CES1) was inhibited. Importantly, lansoprazole can significantly alleviate rat hepatic lipid deposition in hypercholesterolemia models by inducing CYP1A. Our findings reveal the role of CYP1A as a potential regulator of cholesterol homeostasis and provide a new perspective for the treatment of hypercholesterolemia.